Works matching DE "GASTRIC inhibitory polypeptide"
Results: 405
Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 8, p. 721, doi. 10.1080/17512433.2024.2363838
- By:
- Publication type:
- Article
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association
- Published in:
- Anaesthesia, 2025, v. 80, n. 4, p. 412, doi. 10.1111/anae.16541
- By:
- Publication type:
- Article
Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 3, p. e901, doi. 10.1210/clinem/dgae435
- By:
- Publication type:
- Article
Hormonal regulation of human adipose tissue lipolysis: impact of adipose GIP system in overweight and obesity.
- Published in:
- European Journal of Endocrinology, 2025, v. 192, n. 2, p. 91, doi. 10.1093/ejendo/lvae151
- By:
- Publication type:
- Article
Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials.
- Published in:
- Diabetes Care, 2025, v. 48, n. 3, p. 430, doi. 10.2337/dc24-1773
- By:
- Publication type:
- Article
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 9, doi. 10.1007/s10557-024-07630-9
- By:
- Publication type:
- Article
The new dual gastric inhibitory peptide/glucagon‐like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 8, p. 1, doi. 10.1002/dmrr.3503
- By:
- Publication type:
- Article
Glucagon in type 1 diabetes patients receiving SGLT2 inhibitors: A Friend or Foe?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 5, p. 1, doi. 10.1002/dmrr.3415
- By:
- Publication type:
- Article
Enzymatically stable analogue of the gut‐derived peptide xenin on beta‐cell transdifferentiation in high fat fed and insulin‐deficient Ins1<sup>Cre/+</sup>;Rosa26‐eYFP mice.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 3, p. 1, doi. 10.1002/dmrr.3384
- By:
- Publication type:
- Article
Nicotinamide riboside supplementation to improve skeletal muscle mitochondrial health and whole‐body glucose homeostasis: does it actually work in humans?
- Published in:
- Journal of Physiology, 2020, v. 598, n. 4, p. 619, doi. 10.1113/JP279280
- By:
- Publication type:
- Article
Early life stress determines insulin signalling in adulthood.
- Published in:
- Journal of Physiology, 2020, v. 598, n. 3, p. 427, doi. 10.1113/JP279300
- By:
- Publication type:
- Article
Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00476
- By:
- Publication type:
- Article
Sitagliptin and fucoidan prevent apoptosis and reducing ER stress in diabetic rat testes.
- Published in:
- Andrologia, 2021, v. 53, n. 3, p. 1, doi. 10.1111/and.13858
- By:
- Publication type:
- Article
Effects of Heat Stress on Gut-Microbial Metabolites, Gastrointestinal Peptides, Glycolipid Metabolism, and Performance of Broilers.
- Published in:
- Animals (2076-2615), 2021, v. 11, n. 5, p. 1286, doi. 10.3390/ani11051286
- By:
- Publication type:
- Article
Omega-3FAs Can Inhibit the Inflammation and Insulin Resistance of Adipose Tissue Caused by HHcy Induced Lipids Profile Changing in Mice.
- Published in:
- Frontiers in Physiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphys.2021.628122
- By:
- Publication type:
- Article
Small molecule glucagon release inhibitors with activity in human islets.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1114799
- By:
- Publication type:
- Article
A systematic review of the safety of tirzepatide-a new dual GLP1 and GIP agonist - is its safety profile acceptable?
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1121387
- By:
- Publication type:
- Article
Ingestion of whey protein and β-conglycinin exerts opposite effects on intestinal FGF15 and serotonin secretion in mice.
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1080790
- By:
- Publication type:
- Article
A review on phytochemical and pharmacological facets of tropical ethnomedicinal plants as reformed DPP-IV inhibitors to regulate incretin activity.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1027237
- By:
- Publication type:
- Article
Noninvasive Evaluation of GIP Effects on β-Cell Mass Under High-Fat Diet.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.921125
- By:
- Publication type:
- Article
pH-Dependence of Glucose-Dependent Activity of Beta Cell Networks in Acute Mouse Pancreatic Tissue Slice.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.916688
- By:
- Publication type:
- Article
Pharmacological mechanisms of hormone action in hypoglycemia: Maintaining glucose balance.
- Published in:
- African Journal of Diabetes Medicine, 2023, v. 31, n. 3, p. 1, doi. 10.54931/AJDM-31.3.8
- By:
- Publication type:
- Article
Neprilysin expression in pancreatic cells plays a protective role against pancreatic cell dysfunction.
- Published in:
- African Journal of Diabetes Medicine, 2023, v. 31, n. 2, p. 1
- By:
- Publication type:
- Article
Type 2 Diabetes patients and their Glucagonostatic potency (GLP-1).
- Published in:
- African Journal of Diabetes Medicine, 2021, v. 29, n. 5, p. 20
- By:
- Publication type:
- Article
Commentary on "Intra‐islet α‐cell Gs signaling promotes glucagon release".
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Regulation of glucose and energy metabolism through actions of glucagon‐like peptide‐1 and glucose‐dependent insulinotropic polypeptide.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 12, p. 1725, doi. 10.1111/jdi.14305
- By:
- Publication type:
- Article
Role of β‐cell autophagy in β‐cell physiology and the development of diabetes.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 6, p. 656, doi. 10.1111/jdi.14184
- By:
- Publication type:
- Article
Effects of dipeptidyl peptidase‐4 inhibition in vivo: Dipeptidyl peptidase‐4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 6, p. 704, doi. 10.1111/jdi.14157
- By:
- Publication type:
- Article
Glucose-dependent insulinotropic polypeptide receptor systems in the hypothalamus and the brainstem regulate feeding and weight through distinct pathways.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 3, p. 282, doi. 10.1111/jdi.14130
- By:
- Publication type:
- Article
Stimulatory effect of imeglimin on incretin secretion.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 6, p. 746, doi. 10.1111/jdi.14001
- By:
- Publication type:
- Article
Updates of incretin‐related drugs for the treatment of type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 2, p. 189, doi. 10.1111/jdi.13945
- By:
- Publication type:
- Article
Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1's better half?
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 6, p. 1422, doi. 10.1111/jdi.13302
- By:
- Publication type:
- Article
Effects of metformin on blood glucose levels and bodyweight mediated through intestinal effects.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 6, p. 1420, doi. 10.1111/jdi.13301
- By:
- Publication type:
- Article
New concept of the glucagon‐like peptide‐1 signaling pathway on pancreatic insulin secretion.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 2, p. 265, doi. 10.1111/jdi.13136
- By:
- Publication type:
- Article
Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 6, p. 1405, doi. 10.1111/jdi.13135
- By:
- Publication type:
- Article
Free fatty acid receptors, G protein‐coupled receptor 120 and G protein‐coupled receptor 40, are essential for oil‐induced gastric inhibitory polypeptide secretion.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 6, p. 1430, doi. 10.1111/jdi.13059
- By:
- Publication type:
- Article
The journey to understanding incretin systems: Theory, practice and more theory.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 5, p. 1171, doi. 10.1111/jdi.13123
- By:
- Publication type:
- Article
Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 1, p. 21, doi. 10.1111/jdi.12718
- By:
- Publication type:
- Article
Novel extrapancreatic effects of incretin.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 76, doi. 10.1111/jdi.12495
- By:
- Publication type:
- Article
Alternative form of glucose-dependent insulinotropic polypepide and its physiology.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 33, doi. 10.1111/jdi.12445
- By:
- Publication type:
- Article
Anti-atherogenic and anti-inflammatory properties of glucagon-like peptide-1, glucose-dependent insulinotropic polypepide, and dipeptidyl peptidase-4 inhibitors in experimental animals.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 80, doi. 10.1111/jdi.12446
- By:
- Publication type:
- Article
Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 27, doi. 10.1111/jdi.12449
- By:
- Publication type:
- Article
Mechanisms of fat-induced gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide secretion from K cells.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 20, doi. 10.1111/jdi.12467
- By:
- Publication type:
- Article
Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 4, doi. 10.1111/jdi.12480
- By:
- Publication type:
- Article
Searching for the physiological role of glucose-dependent insulinotropic polypeptide.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 8, doi. 10.1111/jdi.12488
- By:
- Publication type:
- Article
Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 13, doi. 10.1111/jdi.12478
- By:
- Publication type:
- Article
Cardiovascular effects of the incretin-based therapy: the good, the bad, or the ugly?
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Fructose induces glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and insulin secretion: Role of adenosine triphosphate-sensitive K<sup>+</sup> channels.
- Published in:
- Journal of Diabetes Investigation, 2015, v. 6, n. 5, p. 522, doi. 10.1111/jdi.12356
- By:
- Publication type:
- Article
Incretin physiology and pathophysiology from an Asian perspective.
- Published in:
- Journal of Diabetes Investigation, 2015, v. 6, n. 5, p. 495, doi. 10.1111/jdi.12305
- By:
- Publication type:
- Article
Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice.
- Published in:
- Journal of Diabetes Investigation, 2014, v. 5, n. 1, p. 31, doi. 10.1111/jdi.12129
- By:
- Publication type:
- Article